Skip to main content

Animations

MJFF Publications

3791 - 3800 of 8808 Results
Title
Year
  • Year
  • 2012
  • 2018
  • 2011
  • 2017
  • 2012
  • 2015
  • 2013
  • 2011
  • 2014
  • 2014
  • Summary Details
    OPEN
    Title: Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1205102109
    Citation Count: 87
  • Summary Details
    OPEN
    Title: A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41593-018-0298-7
    Citation Count: 217
  • Summary Details
    OPEN
    Title: In vivo demonstration that α-synuclein oligomers are toxic
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1100976108
    Citation Count: 1395
  • Summary Details
    OPEN
    Title: The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-017-05760-9
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies
    Journal Name: mAbs
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.4161/mabs.21696
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001708
    Citation Count: 158
  • Summary Details
    OPEN
    Title: Pure hereditary spastic paraplegia due to a de novo mutation in the NIPA1 gene
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.12284
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1
    Citation Count: 93
  • Summary Details
    OPEN
    Title: The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26065
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Peptidoglycan recognition protein genes and risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25895
    Citation Count: 48
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.